2 min read
The Rise of Decentralized Clinical Trials: Transforming Research Through Technology and Patient-Centricity
Learn how decentralized clinical trials (DCTs) are reshaping the clinical research landscape. Explore the insights...
1 min read
SOUTHBOROUGH, MA – July 13, 2015 – Veristat, a full service Clinical Research Organization (CRO), announced today that it has completed the move of its corporate headquarters to Southborough, Massachusetts. As previously announced, the move was driven by Veristat’s rapid growth in response to the increased demand for full-service clinical research offerings by its pharmaceutical and biotechnology clients.
Veristat moved its Corporate Headquarters to 118 Turnpike Road (Route 9 Eastbound) in Southborough, Massachusetts where it just finished remodeling the entire second floor comprising 33,000 sf of Class A space. The new headquarters is specifically designed to foster more clinical team collaboration and customer engagement, and the location is more convenient and accessible to clients in the greater Boston area. The office is home to Veristat’s corporate/administrative teams, and operational teams including clinical monitors, project managers, data managers, biostatisticians, statistical programmers and medical writers.
In addition to its corporate headquarters office, Veristat has additional offices in Cambridge, MA, Montreal, Canada and the recently opened Bay Area office in San Bruno, CA.
The new Veristat Headquarters office address is: 118 Turnpike Road Southborough, MA 01772 Phone: (508) 429-7340 info@veristat.com
About Veristat
Veristat, LLC is an innovative full-service, science-focused clinical research organization (CRO) with over 20 years of experience in supporting clinical trials and regulatory submissions for pharmaceutical, biotechnology, and medical device companies. Veristat offers comprehensive clinical development services, including biostatistics, statistical programming, medical writing, clinical monitoring and data management, for a single study or an entire clinical program, as well as preparation of integrated summary documents and submission-ready CDISC data for regulatory filings. Due to Veristat’s unwavering commitment to scientific integrity, client focus and exceptional performance, long-lasting client relationships are our hallmark. For more information, please visit www.veristat.com.
Veristat Contact: Gillian Dellacioppa, Marketing Director Gillian.dellacioppa@veristat.com or 508-306-6336